Zanwar, Saurabh http://orcid.org/0000-0001-5074-8453
Nandakumar, Bharat
Kumar, Shaji http://orcid.org/0000-0001-5392-9284
Article History
Received: 19 June 2020
Revised: 24 July 2020
Accepted: 27 July 2020
First Online: 22 August 2020
Conflict of interest
: S.K.—research funding for clinical trials to the institution: Celgene, Takeda, Janssen, BMS, KITE, Merck, Abbvie, Medimmune, Novartis, Roche-Genentech, Amgen, Tenebio, Carsgen; Consulting/Advisory Board participation (with no personal payments): Celgene, Takeda, Janssen, Abbvie, Genentech, Amgen, Molecular Partners and (with personal payment) Oncopeptides, Genecentrix, Cellectar. The remaining authors have no conflicts of interest to disclose.